Phase 1 Trial of <i>Withania somnifera</i> Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [ <sup>18</sup> F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials
- DOI
- 10.1177/15347354251410182
- Published
- 2026-02
- Container
- Integrative Cancer Therapies
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/15347354251410182,
title = {Phase 1 Trial of
<i>Withania somnifera</i>
Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [
<sup>18</sup>
F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials},
author = {Jin Uk Heo and Santosh Rao and Herbert B. Newton and Afshin Dowlati and Raymond F. Muzic and Arash Kardan},
year = {2026},
journal = {Integrative Cancer Therapies},
doi = {10.1177/15347354251410182},
url = {https://doi.org/10.1177/15347354251410182}
}RIS
TY - JOUR
TI - Phase 1 Trial of
<i>Withania somnifera</i>
Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [
<sup>18</sup>
F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials
AU - Jin Uk Heo
AU - Santosh Rao
AU - Herbert B. Newton
AU - Afshin Dowlati
AU - Raymond F. Muzic
AU - Arash Kardan
PY - 2026
JO - Integrative Cancer Therapies
DO - 10.1177/15347354251410182
UR - https://doi.org/10.1177/15347354251410182
ER - APA
Heo, J. U., Rao, S., Newton, H. B., Dowlati, A., Muzic, R. F., & Kardan, A. (2026). Phase 1 Trial of <i>Withania somnifera</i> Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [ <sup>18</sup> F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials. Integrative Cancer Therapies. https://doi.org/10.1177/15347354251410182
Source records
- crossref · retrieved 2026-09-25T19:43:41.472Z